SEVERE ASTHMA RESEARCH PROGRAM (SARPII) IMAGING CORE
SEVERE ASTHMA RESEARCH PROGRAM (SARPII) IMAGING CORE
批准号:
7615583
负责人:
Mario Castro
金额:
$37.41万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-04-15 至 2012-02-29
关键词:
AdultAirAnti-Inflammatory AgentsAnti-inflammatoryAreaAsthmaAwardBiopsyBronchoscopyChestClinicClinicalClinical TrialsClinical Trials Data Monitoring CommitteesComputersDataData Coordinating CenterData SetDiseaseEnrollmentFunctional disorderFundingGoalsImageImage AnalysisImaging TechniquesIndividualInjuryInterventionIowaLeadLinkMeasurableMeasuresMethodsMonitorMorphologyNational Heart, Lung, and Blood InstituteOutcomePathologicPatientsPatternPerformancePhysiologicalProcessProtocols documentationResearchResearch PersonnelResourcesRespiratory physiologySamplingSiteStimulusStructureTechnologyTestingThickTimeTissuesUniversitiesWashingtonWisconsinaggressive therapyairway inflammationairway remodelingbasecohortcomparison groupdata acquisitionforestimaging modalityimprovedmeetingsparent grantprognosticprogramsrepairedvalidation studiesvirtual
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant):
The overall goal of this Ancillary RFA proposal is to better understand whether an imaging modality using multidetector-row CT (MDCT) chest can provide a noninvasive measure of airway remodeling in asthma. The Severe Asthma Research Program's (SARPII) central hypothesis is that severe asthma is a consequence, in part, of numerous interactive processes that lead not only to airway inflammation, injury, and altered repair mechanisms, but that there is dysregulation of selected anti-inflammatory processes that normally modulate the injury pattern leading to airway remodeling. In this proposal, we will utilize this unique resource of prospectively enrolled and carefully characterized subjects with severe asthma and appropriate comparison groups (mild- moderate asthma, normal subjects). We propose to add an Imaging protocol to SARPII that will include an Imaging Core (University of Iowa), Morphology Core (Washington University/University of Pittsburgh), and a Biostats Core (Washington University). As part of this proposal, subjects will undergo MDCT chest then bronchoscopy with guided imaging to direct where endobronchial biopsies can be obtained for the optimal sampling of a remodeled airway. We propose that validating this technology in a well- characterized cohort of adult subjects (n=200) with severe and mild asthma and normal subjects will provide a valuable, clinically useful, noninvasive measure of airway remodeling. Accordingly, in order to better define whether MDCT chest can be used as a noninvasive, indirect measure of airway remodeling in severe asthma in comparison to mild asthma or normal and diseased controls, we propose the following aims: I. Standardize and assess the reliability of a common imaging protocol including both data acquisition and image analysis using MDCT in a well-characterized cohort of subjects with severe asthma in comparison to subjects with mild asthma and normal controls from the SARPII study. II. Investigate whether radiographic measures of airway thickness correlate with pathologic and physiologic markers in subjects with mild and severe asthma and in comparison to normal controls from the SARPII study. III. Investigate the use of imaging with MDCT to prospectively identify sites of airway remodeling and guide targeted bronchoscopic assessment with endobronchial tissue biopsy in subjects with mild and severe asthma and in comparison to normal controls from the SARPII study. Airway remodeling is felt to contribute to the long term decline in lung function that occurs in asthma. We propose that evaluating a new imaging technique, multidetector-row CT (MDCT) chest, in a well-characterized group of subjects with severe and mild asthma and normal subjects will provide a valuable, clinically useful, noninvasive measure of airway remodeling. This measure of airway remodeling may help identify individuals with asthma who are likely to develop severe disease and who may benefit from early targeted, aggressive therapy. (End of Abstract)
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
University of Kansas' Precision Biologic Interventions for Severe Exacerbation Prone Asthma (PrecISE) Clinical Center
-
批准号:10223411
-
项目类别:
-
资助金额:$39.43万
-
财政年份:2019
-
负责人:Mario Castro
-
依托单位:
University of Kansas' Precision Biologic Interventions for Severe Exacerbation Prone Asthma (PrecISE) Clinical Center
-
批准号:10455084
-
项目类别:
-
资助金额:$34.54万
-
财政年份:2019
-
负责人:Mario Castro
-
依托单位:
WASHINGTON UNIVERSITY'S PRECISION BIOLOGIC INTERVENTIONS FOR SEVERE EXACERBATION PRONE ASTHMA (PRECISE) CLINICAL CENTER
-
批准号:9751957
-
项目类别:
-
资助金额:$6.53万
-
财政年份:2017
-
负责人:Mario Castro
-
依托单位:
Frontiers Clinical and Translational Science Institute at the University of Kansas
-
批准号:10674055
-
项目类别:
-
资助金额:$381.79万
-
财政年份:2017
-
负责人:Mario Castro
-
依托单位:
Frontiers Clinical and Translational Science Institute at the University of Kansas
-
批准号:10557271
-
项目类别:
-
资助金额:$370.45万
-
财政年份:2017
-
负责人:Mario Castro
-
依托单位:
Frontiers Clinical and Translational Science Institute at the University of Kansas
-
批准号:10702087
-
项目类别:
-
资助金额:$11.23万
-
财政年份:2017
-
负责人:Mario Castro
-
依托单位:
Frontiers: University of Kansas Clinical and Translational Science Institute
-
批准号:10474055
-
项目类别:
-
资助金额:$121.15万
-
财政年份:2017
-
负责人:Mario Castro
-
依托单位:
WASHINGTON UNIVERSITY'S PRECISION BIOLOGIC INTERVENTIONS FOR SEVERE EXACERBATION PRONE ASTHMA (PRECISE) CLINICAL CENTER
-
批准号:9406430
-
项目类别:
-
资助金额:$27.54万
-
财政年份:2017
-
负责人:Mario Castro
-
依托单位:
Quality Control/Quality Assurance Reviews for CTSA Submissions
-
批准号:10159055
-
项目类别:
-
资助金额:$14.72万
-
财政年份:2017
-
负责人:Mario Castro
-
依托单位:
Washington University K12 Program in T4 Implementation Research
-
批准号:9371396
-
项目类别:
-
资助金额:$9.03万
-
财政年份:2017
-
负责人:Mario Castro
-
依托单位:
Frontiers: University of Kansas Clinical and Translational Science Institute
-
批准号:10215281
-
项目类别:
-
资助金额:$417.1万
-
财政年份:2017
-
负责人:Mario Castro
-
依托单位:
Severe Asthma Research Program (SARP)-Washington University
-
批准号:8177286
-
项目类别:
-
资助金额:$56.08万
-
财政年份:2011
-
负责人:Mario Castro
-
依托单位:
Severe Asthma Research Program (SARP)-Washington University
-
批准号:8509010
-
项目类别:
-
资助金额:$65.22万
-
财政年份:2011
-
负责人:Mario Castro
-
依托单位:
Severe Asthma Research Program (SARP)-Washington University
-
批准号:8680349
-
项目类别:
-
资助金额:$64.71万
-
财政年份:2011
-
负责人:Mario Castro
-
依托单位:
Severe Asthma Research Program (SARP)-Washington University
-
批准号:8316391
-
项目类别:
-
资助金额:$66.25万
-
财政年份:2011
-
负责人:Mario Castro
-
依托单位:
SEVERE ASTHMA RESEARCH PROGRAM (SARPII) IMAGING CORE
-
批准号:7777824
-
项目类别:
-
资助金额:$37.27万
-
财政年份:2008
-
负责人:Mario Castro
-
依托单位:
SEVERE ASTHMA RESEARCH PROGRAM (SARPII) IMAGING CORE
-
批准号:8032476
-
项目类别:
-
资助金额:$37.27万
-
财政年份:2008
-
负责人:Mario Castro
-
依托单位:
AIRWAY REMODELING IN SEVERE ASTHMA
-
批准号:7603318
-
项目类别:
-
资助金额:$0.37万
-
财政年份:2007
-
负责人:Mario Castro
-
依托单位:
MECHANISM OF AIRWAY INFLAMMATION: VIRAL RESPIRATORY TRACT INFECTION ASSOCIATED
-
批准号:7603387
-
项目类别:
-
资助金额:$0.08万
-
财政年份:2007
-
负责人:Mario Castro
-
依托单位:
GENETIC, BIOLOGIC AND IMMUNOLOGIC DETERMINANTS OF ASTHMA
-
批准号:7603384
-
项目类别:
-
资助金额:$2.26万
-
财政年份:2007
-
负责人:Mario Castro
-
依托单位:
国内基金
海外基金
湍流和化学交互作用对H2-Air-H2O微混燃烧中NO生成的影响研究
-
批准号:51976048
-
项目类别:面上项目
-
资助金额:61.0万元
-
批准年份:2019
-
负责人:邱朋华
-
依托单位: